TAT-CIRP
目录号 : KM32988
TAT-CIRP 是一种小肽,是指反式反式激活 (Tat) 冷诱导 RNA 结合蛋白。TAT-CIRP 是骨髓分化蛋白 2 (MD2) 的抑制剂。TAT-CIRP 对小鼠缺血性和出血性中风表现出强大的神经保护作用。
规格 价格 是否有货 数量
1mg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

TAT-CIRP is a a small peptide, refers to Trans-trans-activating (Tat)-cold-inducible RNA binding protein. TAT-CIRP is an inhibitor of myeloid differentiation protein 2 (MD2). TAT-CIRP exhibits robust neuroprotection against ischemic and hemorrhagic stroke in mice.

体外研究

TAT-CIRP (5 μM) alleviates NMDA-induced apoptosis and necrosis in neuronal cells (50 μM; 1 hour) via a TLR4-independent pathway.

体内研究

TAT-CIRP (5-20mg/kg) alleviates brain damage after ischemic stroke in mice with middle cerebral artery (MCAO) occlusion. As for Tat, the cell membrane transduction domain of human immunodeficiency virus type 1 can be used as a control peptide .
TAT-CIRP (20 mg/kg; intravenous injection; Single dose) can pass through the blood-brain barrier in mice, with a Cmax value of 4762.6 μ g/L and a half-life of approximately 90 minutes.
TAT-CIRP (20 mg/kg, 100 mg/kg; intravenous injection; Once a day for 7 days) has almost no toxicity to mice and is safe.
TAT-CIRP reduces cerebral ischemic injury in rhesus monkeys.

 

Animal Model: Middle cerebral artery (MCA) occlusion (MCAO) model in mouse
Dosage: 5 mg/kg, 10 mg/kg, 20 mg/kg
Administration:
IV; single dose or once daily for 7 days
Result: Resulted better neurological function at 28 days after brain hemorrhage than the mice that received saline.
Did not induce elevation of any liver transaminases or biomarkers of renal dysfunction.
 
分子式
C123H206N56O33
分子量
2997.31
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式

2-8°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。